Healthcare

This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contai...

28 Sep 2015  |  Asia Pacific

End-User Perspectives on the SEA RIS/ PACS Market

Next-generation Imaging IT Needs Will Focus on Interoperability

Infographics

×

Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

As the hype continues around Big Data, its ambiguous nature continues to obscure the potential applications of the technology. Clarity is beginning to emerge within the A&D community about how Big Data can be leveraged for 'intelligence amplification' and companies are beginning to respond. This research aims to define these emerging applications a...

Healthcare information technology systems to support provider financial management is a key area of growth and interest in the market. With shifts in models to value-based payments (VBR), this entails more financial risk for providers. Successful management of the transition to VBR can only be achieved when healthcare organizations are clinically a...

A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...

Since the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research service evaluates the US market for the pharmaceutical management o...

A trickle-down effect from healthcare reform, together with a transformation operated from within, is pushing the medical imaging industry into a value-focused environment. Although it does seem that the volume-to-value transition in medical imaging will be more of a gradual process than an overnight change, it is already well underway. Its impact ...

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...